Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy
about
The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survivalClaudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapyEmerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesRegulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4Filtering genes to improve sensitivity in oligonucleotide microarray data analysis.Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas.Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.Claudin-containing exosomes in the peripheral circulation of women with ovarian cancerMammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsIdentification of novel keloid biomarkers through profiling of tissue biopsies versus cell cultures in keloid margin specimens compared to adjacent normal skin.Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.Genome-wide profiling of pluripotent cells reveals a unique molecular signature of human embryonic germ cells.Characterization of adult α- and β-globin elevated by hydrogen peroxide in cervical cancer cells that play a cytoprotective role against oxidative insults.Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsSolitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivoPeritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy.Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancerEpithelial-mesenchymal transition in ovarian carcinomaPhosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinomaMAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancerEffects of EHD2 interference on migration of esophageal squamous cell carcinoma.Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapyState of the art in tumor antigen and biomarker discovery.The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profilesPossible angiogenic roles for claudin-4 in ovarian cancer.Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study.Claudin and ovarian cancer.Culture models to define key mediators of cancer matrix remodeling.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Identification of biomarkers involved in differential profiling of hypertrophic and keloid scars versus normal skin.Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activation.
P2860
Q26829844-14711586-4636-4931-9975-86870E5AB771Q26851347-119C1587-7188-4DFC-96C1-65F6CF996F69Q27007065-88BA0FA5-A045-4C4D-82FC-72EBF0C92394Q28534173-4E4B06B1-8B0C-4978-AE8B-0C4BF7AE04B1Q31121932-2FC976D6-D5DD-4E21-9DE3-8BB6A5BFF2C6Q33441919-C92058D0-8152-4921-9A5D-4F5E6FEAC7A8Q33442189-59FA085F-3E46-46AC-AB27-3405F46E88A2Q33484414-D7EB5D2C-BF59-4216-B0A8-1F8B63B68214Q33487445-D6D7C5BB-253B-4AD2-AEBB-0D34DC5AD66EQ33651605-4A38FEBC-F47A-4F05-B085-5B5020EBF45BQ33775215-4A438157-7218-43CE-A3B2-404BB4560627Q34209814-1D2BBF9B-DB1D-4BB2-A83F-50EF06BF4B9CQ34318397-9FB67D1E-1C8E-4D24-9CAE-3AC90229969DQ34562936-AADB13C3-DE87-4DF3-9A85-02845F6B4E21Q34875061-3C327438-C4A4-44AC-B3E6-9E1F1C3337A2Q35006871-E9102A1D-5E74-4AA0-A1D8-AAD8695F59D9Q35007586-47809756-31D1-4B85-98A3-E071E7A07E45Q35121648-E2F4EC49-C6BA-4A31-A793-9E49F6A2721EQ35589596-DF17D75A-3D2D-4641-8DA5-56B002CB3A61Q35659378-E75142CB-9C75-4EB0-9BE7-3BE08427C282Q35971814-EB47092D-59F3-4E67-98C4-D45ECB1D4D1BQ36082365-D6791DD1-029D-4679-ABF4-1F5264319880Q36328328-CF884DA9-C7B9-4319-9C55-4750C5C68D58Q36381924-A1062254-3625-4670-8125-1BB98D71B095Q36438309-4404C347-2C5A-40F0-AE60-EA9F38E95361Q36651059-F0F503AF-3F30-495F-90C7-AC3B7E6966B8Q36859203-7BA8A3A7-C7CB-44BD-B947-D485DA71DA36Q36996794-85B204FF-DFDF-4797-9409-A204CB6AAC51Q37040655-1DADD428-7DFF-44BA-A254-1FA8A87969B8Q37132800-72870FC1-6F78-496E-BF75-AE115E3AC8C5Q37299167-8D5D73A0-29FE-4229-B25F-39F737354BAAQ37480371-9978F4B5-05A4-49C3-B3A6-703B5290A67EQ37522638-62745AFB-7005-4E43-87C6-4A1EB31D031AQ37611453-B1F9DA00-CCCF-4D3D-ABDF-7D3D88533D58Q37676502-30BEFB0B-3157-453D-8690-28426C23971FQ38184632-ED193201-8021-4683-AE74-4BB9FD473FA5Q38304438-116AE82D-E133-47C4-ADB5-02A7798C6B7EQ38432883-A7AC9482-A219-4BDA-8707-68AF020FB4B6Q39112011-D509D31A-9C1C-4440-80D6-30DAC3FFAEF4Q39441192-35053EAA-6090-4399-B175-53CA814A2650
P2860
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy
description
article
@en
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Differential gene expression p ...... or early diagnosis and therapy
@en
Differential gene expression p ...... or early diagnosis and therapy
@nl
type
label
Differential gene expression p ...... or early diagnosis and therapy
@en
Differential gene expression p ...... or early diagnosis and therapy
@nl
prefLabel
Differential gene expression p ...... or early diagnosis and therapy
@en
Differential gene expression p ...... or early diagnosis and therapy
@nl
P2093
P50
P1433
P1476
Differential gene expression p ...... or early diagnosis and therapy
@en
P2093
Alessandro D Santin
Eliana Bignotti
Elisa Rossi
Marcella Falchetti
Renata A Tassi
Sergio Pecorelli
P304
P356
10.1016/J.YGYNO.2006.03.056
P407
P577
2006-05-24T00:00:00Z